Formulation

Apr 01, 2017
BioPharm International
OrlaSURF technology can be used for the development of target-binding assays to monitor the binding of an ADC to its antigen.
Mar 01, 2017
BioPharm International
Communication and taking the time to develop the process are key to successful transfer and scale up of biologics
Jan 01, 2017
BioPharm International
Primary packaging and container design reflects a move to patient-friendly formulations and delivery systems.
Dec 06, 2016
By BioPharm International Editors
Researchers test the efficacy of a new polymer that is an alternative to PEG for drugs used to treat type 2 diabetes.
Dec 01, 2016
BioPharm International
This report describes the first known attempt at quantifying the success of such processes in inducing nucleation on a 56–m2 freeze dryer operating at a load of 195,960 vials.
Dec 01, 2016
BioPharm International
The baculovirus-insect cell system can produce large quantities of complex protein in a short period of time.
Nov 17, 2016
By BioPharm International Editors
Avecia is adding drug substance capacity at its Milford, MA manufacturing site.
Nov 01, 2016
BioPharm International
Interactions between biologic drug products and the components of prefilled syringes can cause protein aggregation, but there are alternative materials that can help mitigate this problem.
Nov 01, 2016
BioPharm International
The development of mAb formulations poses challenges at the manufacturing, stability, analytical, and administration levels.
Oct 20, 2016
By BioPharm International Editors
Prefilled syringes for commercial supply of the etanercept biosimilar will be produced at Catalent’s Brussels facility in Belgium.
native1_300x100
lorem ipsum